Vanguard Group’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $813K | Sell |
|
|||||
|
2025
Q2 | $823K | Sell |
|
|||||
|
2025
Q1 | $1.21M | Sell |
|
|||||
|
2024
Q4 | $4.55M | Buy |
|
|||||
|
2024
Q3 | $5.79M | Buy |
|
|||||
|
2024
Q2 | $6.04M | Sell |
|
|||||
|
2024
Q1 | $9.13M | Buy |
|
|||||
|
2023
Q4 | $11.2M | Buy |
|
|||||
|
2023
Q3 | $8.88M | Buy |
|
|||||
|
2023
Q2 | $10.8M | Buy |
|
|||||
|
2023
Q1 | $7.32M | Buy |
|
|||||
|
2022
Q4 | $3.48M | Sell |
|
|||||
|
2022
Q3 | $3.94M | Hold |
|
|||||
|
2022
Q2 | $5.54M | Sell |
|
|||||
|
2022
Q1 | $12M | Buy |
|
|||||
|
2021
Q4 | $12M | Sell |
|
|||||
|
2021
Q3 | $12.6M | Sell |
|
|||||
|
2021
Q2 | $16M | Buy |
|
|||||
|
2021
Q1 | $8.32M | Sell |
|
|||||
|
2020
Q4 | $7.87M | Sell |
|
|||||
|
2020
Q3 | $6.1M | Sell |
|
|||||
|
2020
Q2 | $6.66M | Buy |
|
|||||
|
2020
Q1 | $4.43M | Buy |
|
|||||
|
2019
Q4 | $4.46M | Buy |
|
|||||
|
2019
Q3 | $4.05M | Sell |
|
|||||
|
2019
Q2 | $3.58M | Sell |
|
|||||
|
2019
Q1 | $7.92M | Sell |
|
|||||
|
2018
Q4 | $5.86M | Buy |
|
|||||
|
2018
Q3 | $9.52M | Buy |
|
|||||
|
2018
Q2 | $8.33M | Buy |
|
|||||
|
2018
Q1 | $6.82M | Sell |
|
|||||
|
2017
Q4 | $5.09M | Sell |
|
|||||
|
2017
Q3 | $5.9M | Buy |
|
|||||
|
2017
Q2 | $3.93M | Buy |
|
|||||
|
2017
Q1 | $3.94M | Buy |
|
|||||
|
2016
Q4 | $4.55M | Buy |
|
|||||
|
2016
Q3 | $4.05M | Buy |
|
|||||
|
2016
Q2 | $4.09M | Sell |
|
|||||
|
2016
Q1 | $4.49M | Buy |
|
|||||
|
2015
Q4 | $4.97M | Buy |
|
|||||
|
2015
Q3 | $4.26M | Buy |
|
|||||
|
2015
Q2 | $6.32M | Buy |
|
|||||
|
2015
Q1 | $6.13M | Buy |
|
|||||
|
2014
Q4 | $5.79M | Buy |
|
|||||
|
2014
Q3 | $4.08M | Buy |
|
|||||
|
2014
Q2 | $4.14M | Sell |
|
|||||
|
2014
Q1 | $4.41M | Buy |
|
|||||
|
2013
Q4 | $4.19M | Sell |
|
|||||
|
2013
Q3 | $4.51M | Buy |
|
|||||
|
2013
Q2 | $3.98M | Buy |
|